By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Quest Diagnostics has teamed up with Beth Israel Deaconess Medical Center and Weill Cornell Medical College to launch a molecular blood test for identifying renal organ transplant rejection.

Quest has also formed R&D collaboration deals with Beth Israel Deaconess and Weill Cornell in the area of renal transplantation, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.